Can Hormel Foods (HRL) Stock Reach $25?

Key Takeaways

• The central $25 target is the arithmetic mean of the most recent individual analyst price targets, which average roughly $25 and range from $23 to $29.
• At a latest price near $21.28, reaching $25 would require an upside move of about 17.5%, a modest but meaningful climb.
• Coverage skews cautious: most analysts rate HRL a Hold, with Barclays (Overweight) and Goldman Sachs (Buy) carrying the more bullish targets.
• Supporting factors include a roughly 5.5% dividend yield, a low forward P/E (price-to-earnings ratio), and an earnings recovery underway, while weak retail volumes and margin pressure remain key risks.
• The stock trades well below its 52-week high near $26.60, so the target sits inside the range the shares have already traveled in the past year.
• For more detail on this ticker's Major News, Today's Price Move, Forecast, and Earnings, explore the dedicated pages for each.
• Investors can also explore Trending AI Robots to see AI-driven strategies tracking stocks and ETFs in real time.

Analyst Price Targets and Consensus View

Hormel Foods Corporation is a stock, not an exchange-traded fund, and it carries active sell-side coverage. Averaging the most recent targets from seven firms — Barclays at $28 (Oct 14), Goldman Sachs at $29 (Oct 2), Piper Sandler at $26 (Oct 6), Bank of America at $24, BNP Paribas Exane at $23, JPMorgan at $23, and Stephens at $23 — produces a mean near $25.1, which rounds to a $25 central target. The low-to-high spread is $23 to $29, a relatively narrow band that reflects a subdued-growth outlook rather than deep disagreement.

Sentiment is decidedly balanced-to-cautious. Barclays (Overweight) and Goldman Sachs (Buy) argue the stock is inexpensive and that margin recovery is underway, while the Hold-rated majority points to persistent volume softness. Recent revisions have leaned lower: Barclays trimmed its target from $30 to $28, BNP Paribas Exane cut from $26 to $23, and JPMorgan earlier downgraded the shares to Neutral from Overweight. No sell ratings are prominent in current coverage.

Current Market Position and Path Toward the Target

Hormel Foods, the maker of brands including Spam, Jennie-O, Planters, Skippy, and Applegate, recently traded near $21.28, giving it a market value of roughly $11.7 billion. Reaching $25 implies about 17.5% upside — a modest move for a low-beta consumer staples name that has already traded as high as $26.60 over the past year. The shares carry a trailing P/E near 34 but a far lower forward P/E of roughly 14, reflecting expectations that earnings will rebound as cost pressures ease.

The path toward the target likely runs through earnings recovery rather than multiple expansion. In its most recent quarter, adjusted EPS (earnings per share) rose about 6% and the company tightened its EPS guidance, even as organic sales slipped about 2% and retail volumes declined. Consensus forecasts call for EPS near $1.48 in fiscal 2026 and about $1.57 in fiscal 2027, implying a modest single-digit growth trajectory that would need to hold steady to support a move back toward $25.

What Could Support a Move Toward the Target

• Income appeal: a dividend near $1.17 per share yields roughly 5.5%, an unusually rich payout that can attract yield-seeking investors if Treasury yields stabilize or fall.
• Attractive valuation: a forward P/E near 14 is below many packaged-food peers, giving the shares room to re-rate if earnings visibility improves.
• Margin recovery: management's cost-savings program, improving turkey supply, and easing input costs are lifting profitability even amid flat-to-lower sales.
• Brand execution: stabilization in the Planters business and international growth, particularly in China, are recurring themes in bullish commentary.

What Could Prevent the Target From Being Reached

• Volume weakness: declining retail volumes and soft organic sales have capped the stock despite better margins.
• Commodity volatility: swings in turkey and pork costs can quickly reverse margin gains, a recurring risk for a protein-heavy portfolio.
• Slow growth: projected EPS growth in the low-to-mid single digits gives analysts little reason to assign a premium multiple.
• Defensive rotation risk: if investors rotate back toward higher-growth sectors, a slow-and-steady staples name could lag even without bad news.

Technical Levels and Market Structure

The shares have been building a base after a long decline. The 52-week range spans roughly $18.96 to $26.60, with the low established in 2026 and recent action recovering from the mid-to-high teens toward the low $20s. The $19-to-$20 zone has acted as a meaningful support area, while the prior high near $26.60 stands as the nearest major resistance. A move to $25 would sit just below that resistance level, meaning the stock would need to absorb selling pressure from investors who bought at higher prices before any sustained breakout.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly 12-month research horizon, and these appear consistent with that convention, though individual firms do not always publish explicit timeframes. The next major catalyst is the company's earnings report, expected around early December 2026, where investors will watch organic sales trends, retail volume, margin progress, and any update to fiscal guidance. Also relevant are input-cost developments, dividend announcements, analyst target revisions, and broader moves in interest rates, which influence the relative appeal of a 5.5%-yielding stock.

AI Daily Buy/Sell Signals

For traders who want a more dynamic view than a 12-month price target, Tickeron's AI Daily Buy/Sell Signals offer a complementary tool. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. Explore the signals to see how AI reads the current tape for HRL and the broader market.

Final Assessment

Can Hormel Foods reach $25? The target is grounded in real analyst work — a mean of roughly $25 across current individual targets that span $23 to $29 — and it sits about 17.5% above the latest price. The stock already traded above $26 within the past year, so the objective is not a stretch on a technical basis. Support comes from a high dividend yield, a low forward multiple, and an earnings recovery that is lifting margins. The main obstacles are persistent retail volume declines, commodity-cost volatility, and a growth profile that keeps most analysts at Hold. Whether the shares reach $25 will depend most on upcoming earnings, guidance, and whether margin gains finally translate into firmer top-line performance. As with any price target, the figure represents analyst expectations, not a guarantee, and it should be weighed alongside an investor's own research and risk tolerance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations